African Institute of Biomedical Science and Technology

Recent papers from African Institute of Biomedical Science and Technology

1. Current knowledge in pharmacogenomics and precision medicine: perspectives of the PGRN global PGx committee on improving drug therapies in underrepresented ethnic populationsPharmacogenomics · 2026
2. Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in ZimbabweFrontiers in Pharmacology · 2026
3. Redefining the geography of pharmaceutical innovation: Kelly Chibale as a harbinger for integrated drug discovery in AfricaFrontiers in Drug Discovery · 2026
4. Doxorubicin-induced early-onset chronic progressive cardiotoxicity, pharmacogenetics and survival among breast cancer patients in ZimbabweSouth African Medical Journal · 2026
5. Albumin–Bilirubin Grade and HIV Status in Hepatocellular Carcinoma as Predictors of Survival in ZimbabweLivers · 2026
6. Measuring capacities to advance global health security and bioeconomic development on the African continentInternational Journal of Infectious Diseases · 2026
7. Actionable Pharmacogenomics and Essential Medicines: An Analysis of WHO and African Lists for Safer and Efficacious Drug UseClinical Pharmacology & Therapeutics · 2026
8. The Burden of Adverse Drug Reactions in Africa in the Context of Pharmacogenetics‐Based Clinical GuidelinesClinical Pharmacology & Therapeutics · 2026
9. A Pharmacogenomic Basis for Tolerance of 5-Fluorouracil Following Early, Severe Toxicity from Capecitabine in a CDA Ultrarapid Metabolizer Colon Cancer Patient: A Case ReportCancer Management and Research · 2026
10. Global Investigation of Clinical Implementation Strategies for DPYD Testing to Guide Fluoropyrimidine TherapyClinical and Translational Science · 2025
11. Opportunities and challenges for the implementation of pharmacogenomics in supportive care for gastrointestinal cancer patients in ZimbabwePharmacogenomics · 2025
12. Eschweilenol C and subfractions from Terminalia plants disrupt haemoglobin metabolism, inhibiting Plasmodium falciparum growth at rings and trophozoite stagesMalaria Journal · 2025
13. CYP2D6 Pharmacogenetics in Nigerian Sickle Cell Disease: Phase 1 of Implementing Pharmacogenomics Testing for Effective Care and Treatment in Africa (iPROTECTA) programGates Open Research · 2025
14. Pharmacogenomic Impact on Breast Cancer Survival for Black Zimbabwean Patients on TamoxifenJCO Global Oncology · 2025
15. Incidence and associated risk factors of anti-tuberculosis drug induced liver injury among TB patientsBMC Infectious Diseases · 2025
16. Actionable Pharmacogenomics and Essential Medicines: An Analysis of WHO and African Lists for Safer and Efficacious Drug Use2025
17. Antiproliferative activities of phytochemicals isolated from the leaves of Dolichos kilimandischaricus (Harms) ex Taub. (Fabaceae) on Jurkat and HL-60 leukemic cellsBMC Complementary Medicine and Therapies · 2025
18. Genetic Variation in Hydrochlorothiazide Response‐Related Genes Among Hypertensive Individuals in Soweto, South AfricaClinical and Translational Science · 2025
19. Implementing health economics for pharmacogenomics research translation in AfricaCommunications Medicine · 2025
20. Sickle hemoglobinopathy research in Zimbabwe and Zambia: setting up an international sickle cell disease registryFrontiers in Medicine · 2025